Technical said:There's no point in specualting, just wait a couple weeks and check back. Soon enough we will all find out.
VANCOUVER, BC – April 3, 2012 – RepliCel Life Sciences Inc. (the “Company†or “RepliCelâ€) (OTCBB: REPCF) is pleased to report that all 19 subjects have completed their six-month post injection follow-up visit and the company remains on schedule to release the initial review of efficacy results in April 2012.
Read it again, because that's not what it said. Late april.dudemon said:Actually, I read their press release that came out about a week ago. Right now, they are in the process of collecting the data from phase I trials, and will disclose the analysis and results in the fall of this year, probably in Sep-Oct. Unless, of course, some info gets leaked somehow, which isn't likely because they keep a pretty tight lid on things due to the whole competitive nature of this study.
so, we wait again ... until fall for the results.
TravisB said:Hmm Replicel's stock seems to be dropping fast recently. I hope it's not a bad sign :dunno:
William Patalon & Keith Fitz-Gerald of Money Morning discuss Big Pharma's new acquisition strategy http://www.thelifesciencesreport.com/pub/na/13070
Good Morning,
At this time, the data is still being analysed. There is no final date when this process will be completed. As soon as it is completed RepliCel will issue a news release.
Thom said:I'm moving on. They said they would release findings this month and now they're going back on that statement. They'll fall through like the rest.
Tired of these bs companies. Shifting into the s.a.f skeptic train of thought.
Data from Phase I of #RepliCel’s clinical trial is expected to be available in late-April, 2012.
Data from Phase I of #RepliCel’s clinical trial is expected to be available in late-April, 2012.
Data from Phase I of #RepliCel’s clinical trial is expected to be available in late-April, 2012.
Data from Phase I of #RepliCel’s clinical trial is expected to be available in late-April, 2012.
Data from Phase I of #RepliCel’s clinical trial is expected to be available in late-April, 2012.
Data from Phase I of #RepliCel’s clinical trial is expected to be available in late-April, 2012.
Data from Phase I of #RepliCel’s clinical trial is expected to be available in late-April, 2012.
Data from Phase I of #RepliCel’s clinical trial is expected to be available in late-April, 2012.